ClinicalTrials.Veeva

Menu

Comparing the Effect of Spinal Bupivacaine Versus Spinal Prilocaine on Maternal Blood Pressure in Cesarean Section

S

South Valley University

Status

Not yet enrolling

Conditions

Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

Treatments

Drug: Bupivacaine
Drug: Prilocaine

Study type

Interventional

Funder types

Other

Identifiers

NCT06290583
Prilocaine in cesarean section

Details and patient eligibility

About

one of the most common complications associated with spinal anesthesia is hypotension, which can have adverse effects on both the mother and the fetus. The present study compare prilocaine versus bupivacaine in spinal anesthesia on hypotension and there effect on maternal outcomes.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant >36 weeks singleton baby
  • American Society of Anesthesiologists (ASA) physical status 2
  • Age : between 18 years old and 35 years old

Exclusion criteria

  • Pregnant women with cardiac disease and history of psychiatric illness
  • Pregnant women who received spinal anesthesia and converted to general anesthesia
  • Women who have sensitivity to local anesthetics,
  • Women who have Eclampsia, abruption placenta or placenta previa
  • Women who have coagulopathy, thrombocytopenia with platelet count less than 80,000/cm3, myasthenia

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Group B
Active Comparator group
Description:
Patients will be given spinal anesthesia with bupivacaine (10 mg) added to morphine (100 microgram) and will be diluted with 0.9% saline to the 3 ml final volume to be injected.
Treatment:
Drug: Bupivacaine
Group P
Active Comparator group
Description:
Patients will be given spinal anesthesia with prilocaine (50 mg) added to morphine (100 microgram) and will be diluted with 0.9% saline to the 3 ml final volume to be injected.
Treatment:
Drug: Prilocaine

Trial contacts and locations

0

Loading...

Central trial contact

Zeinab M Sayed, MD; Mohamed G Ahmed, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems